SCHEMBL15066522

SCHEMBL15066522

C=CCOc1[c]ccc(F)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HTR2A P28223 5/20 0.37
HTR2C P28335 5/20 0.37
CA12 O43570 3/20 0.34
CA1 P00915 3/20 0.34
CA9 Q16790 3/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34
KAT6A Q92794 2/20 0.32
TSHR P16473 2/20 0.32
POLB P06746 1/20 0.32
MAPK1 P28482 1/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MAOA P21397 2/20 0.32
MAOB P27338 2/20 0.32
ADRA2A P08913 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846804 0.80 MAPT (0.42) MAPTCA12CA1CA9CA2
SCHEMBL15068102 0.79 GAA (0.43) MAPTL3MBTL1HTR2AHTR2CCA12
SCHEMBL6600620 0.79 ALDH1A1 (0.33) MAPTCA12CA1CA9CA2
SCHEMBL28403962 0.79 HPGD (0.42) MAPTCA12CA1CA9CA2
SCHEMBL27947525 0.76 CA12 (0.33) MAPTHTR2AHTR2CCA12CA1
SCHEMBL160927 0.76 NQO1 (0.34) L3MBTL1
SCHEMBL13723489 0.74 HTR2A (0.35) HTR2AHTR2CSLC6A4
SCHEMBL16395046 0.74 HTR2C (0.39) MAPTL3MBTL1HTR2AHTR2CMEN1
SCHEMBL17514548 0.73 MAOB (0.36) MAPTL3MBTL1HTR2AHTR2CCA12
SCHEMBL13722619 0.73 NTRK1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113195502-A Macrocyclic influenza endonuclease inhibitors 詹森生物制药有限公司 2021-07-30 CN disclosed
CN-107266382-B Heteroarylpiperidine and piperazine derivatives as fungicides 拜耳知识产权有限责任公司 2020-10-27 CN disclosed
US-10426169-B2 Heteroarylpiperidine and -piperazine derivatives as fungicides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2019-10-01 US disclosed
EP-2921485-B1 ISOXAZOLE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2018-07-18 EP disclosed
EP-2921484-B1 OXAZOLE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2018-07-18 EP disclosed
US-20180103641-A1 HETEROARYLPIPERIDINE AND -PIPERAZINE DERIVATIVES AS FUNGICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-04-19 US disclosed
EP-2921495-B1 HETEROARYLPIPERIDINE AND HETEROARYLPIPERAZINE DERIVATIVES AS FUNGICIDES BAYER IP GMBH (DE) 2018-03-28 EP disclosed
CN-107266382-A It is used as the heteroaryl piperidine and heteroaryl based piperazine derivative of bactericide 拜耳知识产权有限责任公司 2017-10-20 CN disclosed
CN-107266383-A It is used as the heteroaryl piperidine and heteroaryl based piperazine derivative of bactericide 拜耳知识产权有限责任公司 2017-10-20 CN disclosed
CN-107253947-A It is used as the heteroaryl piperidine and heteroaryl based piperazine derivative of bactericide 拜耳知识产权有限责任公司 2017-10-17 CN disclosed
EP-2921494-A1 HETEROARYLPIPERIDINE AND HETEROARYLPIPERAZINE DERIVATIVES Bayer Intellectual Property GmbH (DE) 2015-09-23 EP disclosed
EP-2921493-A1 HETEROARYLPIPERIDINE AND HETEROARYLPIPERAZINE DERIVATIVES Bayer Intellectual Property GmbH (DE) 2015-09-23 EP disclosed
EP-2921481-A1 4-PIPERIDINE CARBOXYLIC ACID DERIVATIVES Bayer Intellectual Property GmbH (DE) 2015-09-23 EP disclosed
EP-2921492-A1 HETEROARYLPIPERIDINE AND HETEROARYLPIPERAZINE DERIVATIVES Bayer Intellectual Property GmbH (DE) 2015-09-23 EP disclosed
EP-2921495-A1 HETEROARYLPIPERIDINE AND HETEROARYLPIPERAZINE DERIVATIVES AS FUNGICIDES Bayer Intellectual Property GmbH (DE) 2015-09-23 EP disclosed
US-20150024935-A1 HETEROARYLPIPERIDINE AND PIPERAZINE DERIVATIVES AS FUNGICIDES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-01-22 US disclosed
EP-2797899-A2 HETEROARYLPIPERIDINE AND PIPERAZINE DERIVATIVES AS FUNGICIDES Bayer Intellectual Property GmbH (DE) 2014-11-05 EP disclosed
CN-104011032-A Heteroarylpiperidine and piperazine derivatives as fungicides BAYER IP GMBH 2014-08-27 CN disclosed
CN-101535276-B 2, 4-diaminopyrimidine fused bicyclic derivatives as ALK and c-MET inhibitors CEPHALON INC 2013-08-28 CN disclosed
WO-2013098229-A2 HETEROARYLPIPERIDINE AND PIPERAZINE DERIVATIVES AS FUNGICIDES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-07-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10426169-B2 Heteroarylpiperidine and -piperazine derivatives as fungicides RB1, RBX1, RRP12 MAPT 4047/4885L3MBTL1 3002/4885HTR2A 1279/4885
US-20180103641-A1 HETEROARYLPIPERIDINE AND -PIPERAZINE DERIVATIVES AS FUNGICIDES RB1, RBX1, RRP12 MAPT 4047/4885L3MBTL1 3002/4885HTR2A 1279/4885
US-20150024935-A1 HETEROARYLPIPERIDINE AND PIPERAZINE DERIVATIVES AS FUNGICIDES RB1, RBX1, RRP12 MAPT 4074/4885L3MBTL1 3006/4885HTR2A 1211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.